These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 9648315

  • 21. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P, Katz PO, Chen Y, Sostek M.
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [Abstract] [Full Text] [Related]

  • 22. Proton pump inhibitors.
    Grover JK, Vats V.
    Trop Gastroenterol; 1999 Dec; 20(1):16-28. PubMed ID: 10464444
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G, Di Fede F.
    Clin Ther; 1993 Dec; 15 Suppl B():2-13. PubMed ID: 7911400
    [Abstract] [Full Text] [Related]

  • 25. Effectiveness of proton pump inhibitors: beyond cost.
    Katz PO.
    Rev Gastroenterol Disord; 2004 Dec; 4 Suppl 4():S8-S15. PubMed ID: 15580146
    [Abstract] [Full Text] [Related]

  • 26. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A.
    N Engl J Med; 1995 Oct 26; 333(17):1106-10. PubMed ID: 7565948
    [Abstract] [Full Text] [Related]

  • 27. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
    Lim PW, Goh KL.
    J Gastroenterol Hepatol; 2004 Sep 26; 19 Suppl 3():S61-8. PubMed ID: 15324384
    [Abstract] [Full Text] [Related]

  • 28. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.
    Orr WC.
    Eur J Gastroenterol Hepatol; 2005 Jan 26; 17(1):113-20. PubMed ID: 15647651
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D, Bagin R, Goldlust B, Major J, Hepburn B.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1467-74. PubMed ID: 15948814
    [Abstract] [Full Text] [Related]

  • 30. [Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?].
    MMW Fortschr Med; 2004 Mar 11; 146(11):54. PubMed ID: 15152770
    [No Abstract] [Full Text] [Related]

  • 31. [Paradigm change in reflux disease. In reflux patients listening to is often more important than endoscopy].
    MMW Fortschr Med; 2004 Nov 04; 146(45):60-1. PubMed ID: 15581111
    [No Abstract] [Full Text] [Related]

  • 32. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB.
    Eur J Gastroenterol Hepatol; 1996 Oct 04; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [Abstract] [Full Text] [Related]

  • 33. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.
    Netzer P, Gut A, Brundler R, Gaia C, Halter F, Inauen W.
    Aliment Pharmacol Ther; 2001 Sep 04; 15(9):1375-84. PubMed ID: 11552908
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of reflux disease. An international consensus conference put things in its place].
    Weber R.
    Rev Med Suisse Romande; 2003 Sep 04; 123(9):3p. PubMed ID: 15095598
    [No Abstract] [Full Text] [Related]

  • 35. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
    Gillessen A.
    MMW Fortschr Med; 2004 Mar 11; 146(11):54. PubMed ID: 15152771
    [No Abstract] [Full Text] [Related]

  • 36. Clinical efficacy of pantoprazole compared with ranitidine.
    Bader JP, Delchier JC.
    Aliment Pharmacol Ther; 1994 Mar 11; 8 Suppl 1():47-52. PubMed ID: 8180294
    [Abstract] [Full Text] [Related]

  • 37. Balanced perspective essential in erosive oesophagitis treatment.
    Gillessen A.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):889-90; author reply 890-1. PubMed ID: 16225500
    [No Abstract] [Full Text] [Related]

  • 38. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO, Tutuian R.
    Best Pract Res Clin Gastroenterol; 2001 Jun 01; 15(3):371-84. PubMed ID: 11403533
    [Abstract] [Full Text] [Related]

  • 39. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U, Abucar A, Hameeteman W, Schneider A, Stockbrügger RW.
    Aliment Pharmacol Ther; 1997 Oct 01; 11(5):959-65. PubMed ID: 9354207
    [Abstract] [Full Text] [Related]

  • 40. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ, Boer WA, Geldof H, Hazelhoff B, Bergmans P, Tytgat GN, Smout AJ.
    Aliment Pharmacol Ther; 2004 Aug 15; 20(4):451-8. PubMed ID: 15298640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.